Skip to main content

Table 1 Participant baseline characteristics

From: The efficacy and safety of ciprofol use for the induction of general anesthesia in patients undergoing gynecological surgery: a prospective randomized controlled study

Patient characteristics Ciprofol group
(n = 60)
Propofol group
(n = 60)
P-value
Age,year, mean ± SDs 33.9 ± 9.1 33.8 ± 9.6 0.626
Height, cm, mean ± SDs 159.3 ± 3.8 158.5 ± 5.2 0.915
Weight, kg, mean ± SDs 56.9 ± 7.9 54.0 ± 9.1 0.991
BMI, kg/m2, mean ± SDs 22.2 ± 3.2 21.4 ± 2.8 0.909
ASA status, n(%)
 I 32(53.3%) 34(56.7%) 0.732
 II 28(46.7%) 26(43.3%) 0.793
Operative duration, min, mean ± SDs 55.2 ± 20.5 51.4 ± 23.1 0.645
  1. BMI Body mass index, ASA American Society of Anesthesiologists